Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

The data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.

Weight loss jabs could reduce the risk of up to 14 types of cancer, new research has found. Mounjaro, Ozempic and other ...

FROM sulphur burps to diarrhoea and nausea, there are many widely known Ozempic side effects – but there’s also a whole host of nasty long-term issues experts are only just uncovering.

Mounjaro, Ozempic and other fat-melting injections have ushered in a new era in the war on obesity, but have also been linked to other benefits, such as slashing heart attack risk.

By Nancy Lapid (Reuters) -Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Experts already know that losing weight reduces the risk of cancer, but now they think weight-loss jabs ... include semaglutide (Wegovy and Ozempic), tirzepatide (Mounjaro), liraglutide (Saxenda) and ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse ... May 19 (UPI) -- With lung cancer rates among non-smokers rising, especially young East Asian women, a new study ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.